BNT162b2 mRNAIgG4IgG

Jerry C H Tam1, Abbie C Sibayan1, Jeffrey Seow1

  • 1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.

Cell reports
|July 12, 2025
PubMed
概括

COVID-19 mRNA疫苗增加了斯派克特异性免疫球蛋白G4 (IgG4) 抗体. 虽然IgG4降低了效应器功能,但它只能在竞争相同的结合位点时抑制保护性抗体活性.